Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 23Breast 12Genitourinary 11Thoracic 7Head & Neck 6Dermatologic 6Gynecologic 4Other 3CNS 3Lymphoid 2Other hematologic neoplasm 1

Conditions

Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 678Cytarabine 576fludarabine 410fludarabine phosphate 387venetoclax 310Methotrexate 297Rituximab 283Azacitidine 264Busulfan 248Whole-Body Irradiation 220Etoposide 215Filgrastim 214Peripheral Blood Stem Cell Transplantation 211Mycophenolic Acid 206Tacrolimus 196Dexamethasone 191Granulocyte Colony-Stimulating Factor 182Vincristine 173Melphalan 173Decitabine 163Cyclosporine 146Daunorubicin 139Antilymphocyte Serum 137Idarubicin 134Imatinib Mesylate 127Lenalidomide 116Doxorubicin 109Radiotherapy 108Stem Cell Transplantation 107Clofarabine 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lidocaine × Other hematologic neoplasm × Clear all
NCT04003012 2023-03-09

Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures

CAMC Health System

Phase 4 Completed
10 enrolled 5 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡